PROactive and Early Infliximab Monitoring and OPTimization in Inflammatory Bowel Disease

IFX therapeutic drug monitoring before the second and third infusion and subsequent dashboard-guided dosing regimes suggested to attending gastroenterologists based on clinical and pharmacokinetics data

No IFX therapeutic drug monitoring before the second and third infusion and subsequent dosing regimes based on clinical data